13F

Stock

Impact Biomedical Inc.

IBO · held by 21 managers

Reported value

$2.23M

Holders

21

+4 new · −9 exited

Holders’ est. mark

$39.4K

Price effect on 14 books still in the name

Largest holder

$716.2K

GEODE CAPITAL MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC1.19M$716.2K$7.1KAdded$678.7K
VANGUARD CAPITAL MANAGEMENT LLC708.2K$424.9KHeld
State Street607.9K$364.7K$1.12KAdded$358.8K
VANGUARD FIDUCIARY TRUST CO585.2K$351.1KHeld
BlackRock, Inc.259.9K$156K$24.7KAdded$24.7K
NORTHERN TRUST CORP243.9K$146.4K$971Added$141.2K
TWO SIGMA INVESTMENTS, LP37.4K$22.5K$3.56KAdded$2.34K
UBS Group AG32.4K$19.4K$206Added$18.4K
Vanguard Global Advisers, LLC32.2K$19.3KHeld
Mason & Associates Inc10K$5.85K$804Added$804
MORGAN STANLEY9.27K$5.56K$880Added$885
Global Trust Asset Management, LLC1.82K$1.09KNew
CITIGROUP INC353$212−$0Added$211
Fidelity290$174New
WELLS FARGO & COMPANY/MN224$134$21Added$21
Newbridge Financial Services Group, Inc.86$52$9Added$9
CWM, LLC28$17$17Added$17
Burk Holdings LLC27$16New
DANSKE BANK A/S3$2$0Held
Center for Financial Planning, Inc.0$1New
ROYAL BANK OF CANADA32$0$0Held

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.